January 2026 in “Current Drug Research Reviews” Natural remedies like caffeine, capsaicin, and essential oils are effective and safer for hair growth.
January 2026 in “Preprints.org” Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.
January 2026 in “British Journal of Health Psychology” Alopecia affects self-confidence, body image, and social interactions, causing distress and requiring better support and awareness.
January 2026 in “SKIN The Journal of Cutaneous Medicine” Androgenetic alopecia patients often experience higher rates of depression and anxiety, suggesting mental health screening before finasteride treatment.
January 2026 in “International Journal of Molecular Sciences” Understanding molecular signals and genetics is key to improving hair regeneration therapies.
January 2026 in “International Journal of Medicine in Developing Countries” Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.
January 2026 in “The American Journal of Medical Sciences and Pharmaceutical Research” Understanding and managing the scalp microbiome is crucial for preventing dandruff, seborrhea, and hair loss.
January 2026 in “Dermatologic Therapy” Microneedling may improve hair loss treatments by enhancing drug delivery and hair growth.
January 2026 in “International Journal of Gynaecology Sciences” PCOS should be redefined as PMOS to better address its complex metabolic issues and improve treatment.
December 2025 in “Egyptian Journal of Basic and Applied Sciences” FOXA1 and CCL2 genes are more active in women with PCOS, varying by phenotype.
December 2025 in “Journal of Cell Communication and Signaling” Vitamin D receptor is crucial for hair health and may help treat hair loss.
December 2025 in “International Journal of Innovative Technologies in Social Science” Localized estrogen treatments may improve skin quality with fewer risks than systemic hormone therapy.
December 2025 in “Chinese Medical Journal” Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.
December 2025 in “Russian Journal of Skin and Venereal Diseases” Mesenchymal stem cells show promise for hair regrowth in androgenetic alopecia, but more research is needed.
December 2025 in “Reports of Morphology” Men with alopecia areata have different body fat distribution compared to healthy men.
December 2025 in “Biomedicines” Addressing body image and weight can help improve female sexual dysfunction.
December 2025 in “International Journal of Clinical Medical Research” Diet and gut health can improve skin, hair, and nails.
The model predicts minoxidil's effectiveness and side effects better than traditional methods.
November 2025 in “Open Repository of the University of Porto (University of Porto)” Minoxidil and spironolactone can improve hair growth, but responses vary and side effects are common.
High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.
November 2025 in “Reumatismo” The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.
Accurate diagnosis is crucial for effective treatment of similar hair loss conditions.
November 2025 in “IntechOpen eBooks” PCOS causes sexual dysfunction, needing comprehensive treatment.
November 2025 in “IECCMEXICO” Regenerative therapies are improving aesthetic surgery by enhancing tissue quality and healing.
November 2025 in “Frontiers in Medicine” Baseline severity and relapse history affect alopecia areata treatment and recurrence.
November 2025 in “Cosmetics” Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.
November 2025 in “Репродуктивное здоровье Восточная Европа” Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.
November 2025 in “Skin Health and Disease” This systematic review identifies 33 genetic syndromes associated with paediatric alopecia areata (AA), highlighting the phenotypic variation in affected children. The study screened 1,426 studies and included 64 that met the criteria, revealing that 67% of the syndromes are fully genetically elucidated, while others are partially or not elucidated. Prevalence estimates show that 45% of these syndromes occur in fewer than 1 in 1,000,000 individuals. The review emphasizes the importance of understanding these syndromes for early prediction, diagnosis, and personalized treatment, despite the limited knowledge and the fact that most syndromes were described in only one report.
November 2025 in “DOAJ (DOAJ: Directory of Open Access Journals)” The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.
October 2025 in “International Journal of Dermatology” Baricitinib is a safe and effective treatment for alopecia areata, with better results in patients with lower initial severity, shorter disease duration, and longer treatment.